3. Materials and Methods
Compounds
1 were prepared according to our previously published method [
13]. All other reagents and solvents were purchased from Sigma-Aldrich, Darmstadt, Germany, and were used as supplied. NMR spectra were generated on a Bruker NEO 400 (400/100 MHz
1H/
13C) spectrometer. Chemical shifts (δ, ppm) were downfield from TMS. TLC was performed on aluminum-backed Silica gel 60 sheets (Merck, Darmstadt, Germany) with KMnO
4 staining. Melting point measurements were carried out in capillary tubes on KRÜSS M5000 automatic mp meter and were not corrected. Mass spectral measurements were performed on a Thermo Fisher Scientific Q Exactive Plus high-resolution mass spectrometer with a heated electrospray ionization source (HESI-II). Petrol refers to the fraction 40–60 °C, NMM refers to N-methylmorpholine, and DMAP refers to 4-dimethylaminopyridine.
Synthesis of β-enaminoamides 2, general procedure: Methylamine (40% aq. solution, 0.45 mL, 5.2 mmol) was added to a solution of the corresponding β-keto amide 1 (5 mmol) in CH2Cl2 (15–20 mL). The mixture was magnetically stirred in a tightly closed vial for 4 h at r.t.; then, anhydrous sodium sulfate was added, and stirring was continued overnight at r.t. Then, the sulfate was filtered off, and the solvent was evaporated under reduced pressure. Compounds 2 crystallized upon trituration with a small volume of diethyl ether and were used in the next step without further purification.
3-Methylamino-4-phenylbut-2-enoic acid phenylamide (2a): m.p. 123–124 °C; 1H-NMR (400 MHz, CDCl3, δ ppm, J Hz): 2.83 (d, J = 5.3, 3H), 3.57 (s, 2H), 4.41 (s, 1H), 6.71 (br s, 1H), 7.03 (m, 1H), 7.27–7.31 (m, 5H), 7.36 (m, 2H), 7.47 (m, 2H), 9.24 (br s, 1H); 13C-NMR (100 MHz, CDCl3, δ ppm): 29.53, 38.74, 86.19, 119.61, 122.82, 126.79, 128.72, 128.84, 136.51, 139.23, 162.60, 169.16; HRMS m/z (ES+): calcd. for C17H19N2O+ [M+H]+ 267.1492, found 267.1490.
3-Methylamino-4-phenylbut-2-enoic acid 4-methoxyphenylamide (2b): m.p. 119–120 °C; 1H-NMR (400 MHz, CDCl3, δ ppm, J Hz): 2.82 (d, J = 5.3, 3H), 3.56 (s, 2H), 3.79 (s, 3H), 4.38 (s, 1H), 6.60 (br s, 1H), 6.84 (m, 2H), 7.28 (m, 3H), 7.35 (m, 4H), 9.20 (br s, 1H); 13C-NMR (100 MHz, CDCl3, δ ppm): 29.51, 38.76, 55.49, 85.91, 114.07, 121.91, 126.74, 128.69, 129.56, 132.22, 136.61, 155.69, 162.21, 169.27; HRMS m/z (ES+): calcd. for C18H21N2O2+ [M+H]+ 297.1598, found 297.1594.
3-Methylamino-4-phenylbut-2-enoic acid 4-chlorophenylamide (2c): m.p. 110–111 °C; 1H-NMR (400 MHz, CDCl3, δ ppm, J Hz): 2.83 (d, J = 5.3, 3H), 3.57 (s, 2H), 4.37 (s, 1H), 6.70 (br s, 1H), 7.23 (m, 2H), 7.28 (m, 3H), 7.35 (m, 2H), 7.41 (m, 2H), 9.21 (br s, 1H); 13C-NMR (100 MHz, CDCl3, δ ppm): 29.55, 38.70, 85.97, 120.59, 126.85, 127.52, 128.72, 128.75, 128.78, 136.34, 137.87, 163.02, 168.94; HRMS m/z (ES+): calcd. for C17H18ClN2O+ [M+H]+ 301.1102, found 301.1107.
Synthesis of α-(2-nitrobenzoyl)-β-enaminoamides 3, general procedure [
11]: 2-nitrobenzoyl chloride (0.13 mL, 1 mmol) was slowly added to a magnetically stirred solution containing the corresponding enaminoamide
2 (1 mmol), 4-methylmorpholine (0.11 mL, 1 mmol) and DMAP (24 mg, 0.2 mmol) in CH
2Cl
2 (20 mL). The mixture was left to stir for 2 h at r.t., and then it was transferred to a separatory funnel with an additional 30 mL of CH
2Cl
2 and washed with dilute aqueous (20:1) HCl. The aqueous layer was extracted again with 25 mL of CH
2Cl
2, the combined organic layers were dried with anhydrous sodium sulfate, the drying agent was removed by filtration, and the solvent was distilled off. The residue was purified by column chromatography on silica gel, using Et
2O–petrol 1:1 as the eluent.
3-Methylamino-2-(2-nitrobenzoyl)-4-phenylbut-2-enoic acid phenylamide (3a): m.p. 125–126 °C; 1H-NMR (400 MHz, DMSO-d6, δ ppm, J Hz): 2.91 (d, J = 5.3, 3H), 3.93 (s, 2H), 6.93 (m, 1H), 7.14 (m, 2H), 7.25 (m, 3H), 7.37 (m, 4H), 7.50 (m, 1H), 7.59 (m, 1H), 7.69 (m, 1H), 8.00 (m 1H), 9.79 (br s, 1H), 11.49 (q, J = 5.3, 1H); 13C-NMR (100 MHz, DMSO-d6, δ ppm): 30.48, 35.68, 109.11, 119.71, 123.76, 124.31, 127.20, 128.88, 129.00, 129.12, 129.94, 134.09, 135.94, 137.75, 139.32, 146.34, 167.20, 167.36, 186.55; HRMS m/z (ES+): calcd. for C24H22N3O4+ [M+H]+ 416.1605, found 416.1605.
3-Methylamino-2-(2-nitrobenzoyl)-4-phenylbut-2-enoic acid 4-methoxyphenylamide (3b): m.p. 157–158 °C; 1H-NMR (400 MHz, DMSO-d6, δ ppm, J Hz): 2.91 (d, J = 5.3, 3H), 3.64 (s, 3H), 3.91 (s, 2H), 6.71 (m, 2H), 7.09 (m, 2H), 7.26 (m, 1H), 7.35 (m, 2H), 7.40 (m, 2H), 7.52 (m, 1H), 7.58 (m, 1H), 7.69 (m, 1H), 8.00 (m, 1H), 9.61 (br s, 1H), 11.46 (q, J = 5.3, 1H); 13C-NMR (100 MHz, DMSO-d6, δ ppm): 30.45, 35.64, 55.55, 114.02, 121.36, 124.29, 124.50, 127.18, 128.92, 129.02, 129.10, 129.44, 129.92, 131.12, 132.42, 133.98, 134.04, 135.99, 137.77, 146.33, 155.78, 166.77, 167.28, 186.48; HRMS m/z (ES+): calcd. for C25H24N3O5+ [M+H]+ 446.1710, found 446.1702.
3-Methylamino-2-(2-nitrobenzoyl)-4-phenylbut-2-enoic acid 4-chlorophenylamide (3c): m.p. 156–157 °C; 1H-NMR (400 MHz, DMSO-d6, δ ppm, J Hz): 2.92 (d, J = 5.3, 3H), 3.91 (s, 2H), 7.19 (m, 2H), 7.25 (m, 3H), 7.35 (m, 4H), 7.50, (m, 1H), 7.57 (m, 1H), 7.69 (m, 1H), 7.99 (dd, J = 8.2, J = 1.0, 1H), 9.94 (br s, 1H), 11.48 (q, J = 5.3, 1H); 13C-NMR (100 MHz, DMSO-d6, δ ppm): 30.51, 35.66, 109.00, 121.07, 124.32, 127.22, 127.29, 128.80, 128.89, 128.98, 129.12, 129.99, 134.11, 135.87, 137.63, 138.29, 146.27, 167.32, 167.40, 186.52; calcd. for C24H21ClN3O4+ [M+H]+ 450.1215, found 450.1220.
Synthesis of 3-methylamino-2-(2-nitrobenzoyl)-4H-naphthalen-1-one (5): Intermediate
3a,
3b, or
3c (1 mmol) was mixed with H
3PO
4 (4–5 g) in a glass vial. The mixture was heated to 60 °C and was magnetically stirred in the course of 2 h at this temperature. After the completion of the reaction, the vial was cooled to r.t. with tap water, and the contents were rinsed and poured into a separatory funnel with 50–70 mL of water. The product was extracted in CH
2Cl
2 (2×40 mL), the combined organic layers were dried (Na
2SO
4), and the solvent was removed under reduced pressure. Trituration and washing with a small volume of diethyl ether gave practically clean product
5 as a white solid: m.p. 174–175 °C;
1H-NMR (400 MHz, CDCl
3, δ ppm,
J Hz): 3.20 (d,
J = 5.3, 3H, CH
3), 4.00 (s, 2H, CH
2), 7.19 (dd,
J = 7.6,
J = 1.2, 1H, C17-H), 7.28 (m, 1H, C6-H), 7.31 (m, 1H, C8-H), 7.45 (m, 1H, C7-H), 7.49 (m, 1H, C15-H), 7.65 (td,
J = 7.5,
J = 1.2, 1H, C16-H), 8.00 (dd,
J = 7.9,
J = 1.0, 1H, C9-H), 8.21 (dd,
J = 8.3,
J = 0.9, 1H, C14-H), 12.20 (br s, 1H, NH);
13C-NMR (100 MHz, CDCl
3, δ ppm): 30.14 (CH
3), 30.37 (CH
2, C4), 107.17 (C2), 123.93 (C14), 126.23 (C17), 126.90 (C9), 127.21 (C6), 127.51 (C8), 127.96 (C15), 131.84 (C7), 133.34 (C5), 134.11 (C16), 141.32 (C12), 144.94 (C13), 171.00 (C3), 181.11 (C1), 194.74 (C11); see
Figure 2 for atom numbering; HRMS
m/
z (ES+): calcd. for C
18H
15N
2O
4+ [M+H]
+ 323.1026, found 323.1025.
Synthesis of 2-Benzyl-4-quinolone-3-carboxamides 6, general procedure [
11]
: Zinc powder (1–1.5 g) was added to the corresponding nitro-intermediate
3 (1 mmol), dissolved in a mixture of CH
2Cl
2 (30 mL) and acetic acid (4 mL). The mixture was magnetically stirred for 24 h at r.t., and then the solids were filtered off with suction and rinsed thoroughly with CH
2Cl
2. The dichloromethane filtrate was transferred to a separatory funnel and extracted with water (50 mL) and then with a saturated aqueous solution of NaHCO
3 (25 mL). The organic phase was dried with anhydrous sodium sulfate, the drying agent was filtered off, and the solvent was removed under reduced pressure. The crude products were purified by column chromatography on silica gel with Et
2O as the eluent, increasing polarity to Et
2O:MeOH 20:1 where necessary.
2-Benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid phenylamide (6a): m.p. 269–270 °C; 1H-NMR (400 MHz, DMSO-d6, δ ppm, J Hz): 4.66 (s, 2H), 7.06 (m, 1H), 7.20 (m, 1H), 7.27–7.35 (m, 6H), 7.47 (m, 1H), 7.68 (m, 3H), 7.77 (m, 1H), 8.26 (m, 1H), 12.23 (s, 1H), 12.41 (br s, 1H); 13C-NMR (100 MHz, DMSO-d6, δ ppm): 38.28, 112.99, 118.84, 120.16, 123.63, 125.13, 125.29, 125.96, 126.90, 128.83, 128.88, 129.27, 133.33, 138.39, 139.00, 139.64, 156.15, 164.45, 176.93; HRMS m/z (ES+): calcd. for C23H19N2O2+ [M+H]+ 355.1441, found 355.1436.
2-Benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 4-methoxyphenylamide (6b): m.p. 240–241 °C; 1H-NMR (400 MHz, DMSO-d6, δ ppm, J Hz): 3.74 (s, 3H), 4.67 (s, 2H), 6.91 (m, 2H), 7.20 (m, 1H), 7.30 (m, 4H), 7.46 (m, 1H), 7.60 (m, 2H), 7.69 (m, 1H), 7.76 (m, 1H), 8.25 (dd, J = 9.4, J = 1.3, 1H), 12.07 (s, 1H), 12.36 (br s, 1H); 13C-NMR (100 MHz, DMSO-d6, δ ppm): 38.21, 55.63, 113.11, 114.39, 118.78, 121.59, 125.05, 125.27, 125.94, 126.88, 128.86, 132.84, 133.26, 138.45, 138.96, 155.64, 155.94, 164.01, 176.88; HRMS m/z (ES+): calcd. for C24H21N2O3+ [M+H]+ 385.1547, found 385.1550.
2-Benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 4-chlorophenylamide (6c): m.p. 260–261 °C; 1H-NMR (70 °C, 400 MHz, DMSO-d6, δ ppm, J Hz): 4.70 (s, 1H), 7.20 (m, 1H), 7.25–7.37 (m, 6H), 7.47 (m, 1H), 7.70 (m, 3H), 7.76 (m, 1H), 8.28 (dd, J = 8.1, J = 1.1, 1H), 12.33 (s, 1H); 13C-NMR (70 °C, 100 MHz, DMSO-d6, δ ppm): 38.37, 112.54, 118.82, 121.89, 125.13, 125.40, 125.99, 126.83, 127.25, 128.81, 129.05, 133.26, 138.35, 138.60, 139.02, 156.62, 164.57, 177.13; HRMS m/z (ES+): calcd. for C23H18ClN2O2+ [M+H]+ 389.1051, found 389.1046.